BCV
ALPN icon

Banque Cantonale Vaudoise’s Alpine Immune Sciences Inc ALPN Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,129
Closed -$798K – 1079
2024
Q1 		$798K Buy
+20,129
New +$594K 0.03% 383

Banque Cantonale Vaudoise's ALPN Position: Q2 2024 in Review

Banque Cantonale Vaudoise sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 20,129 shares — an estimated $798K sold.

Banque Cantonale Vaudoise first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $798K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Banque Cantonale Vaudoise reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 20,129 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $798K.
  • Banque Cantonale Vaudoise first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
  • Banque Cantonale Vaudoise's Alpine Immune Sciences Inc position peaked at $798K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2024, filed 31 Jul 2024.